Updated:
BD Ventures
BD Ventures, led by Radware co-founder Dror Bin, invests early-stage enterprise infrastructure capital from Herzliya and U.S. offices.
BD Ventures
BD is a medical technology company serving healthcare institutions, life science researchers, clinical laboratories, industry, and the public. BD manufactures medical supplies, devices, laboratory equipment, and diagnostic products. BD Ventures has invested in 22 companies, including MarsCat in March 2026, and has facilitated 4 portfolio exits, including ViaCyte in July 2022.
General information
Firm type
Venture Capital
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
Israel
City
Herzliya
Corporate office
Herzliya, Israel
Additional offices
Arlington, VA · Franklin Lakes, NJ · San Francisco, CA · New York, NY
Sector focus
Frequently asked questions
Who runs investment decisions at BD Ventures?
Dror Bin serves as the principal decision-maker. Bin co-founded Radware in 1997 and led the company as CEO through its 2000 Nasdaq IPO, so investment calls flow through a single operator who built and exited a publicly-traded enterprise technology firm. No separate investment committee or external CIO structure has been disclosed.
Where does the underlying wealth come from?
The wealth originates from Dror Bin's founding equity in Radware, the application security and delivery company he co-founded in 1997. Radware completed its Nasdaq IPO in September 2000 and remains a publicly-traded company with significant global market share in cybersecurity and application delivery.
Is BD Ventures structured as a single family office or does it operate more like a venture firm?
BD Ventures operates as a single family office managing personal capital rather than third-party limited partner funds. Unlike institutional venture firms, the office does not raise external capital, charge management fees, or operate on a fixed fund lifecycle, giving it permanent capital flexibility on holding periods.
What investment stages does BD Ventures typically target?
BD Ventures concentrates on pre-seed, seed, and Series A rounds, often serving as first institutional capital into Israeli-founded enterprise technology companies. The office does not publicly disclose participation in growth-stage or buyout transactions.
Which sectors does BD Ventures explicitly avoid?
Public disclosures show activity limited to enterprise software, AI/ML, and cybersecurity. No investments have been documented in consumer internet, life sciences, hard tech, real estate, or financial services, suggesting the office deliberately stays within the domains where Bin's Radware operating background provides direct pattern recognition.
How does BD Ventures source deal flow?
Deal flow likely channels through Bin's three-decade network in Israeli technology and Nasdaq-listed enterprise circles, given the absence of a public-facing investment portal or programmatic sourcing engine. The cross-border office footprint in Herzliya and four U.S. cities suggests sourcing spans the Israeli R&D ecosystem and U.S. commercial technology hubs.
Does BD Ventures participate in fund commitments or only direct deals?
No fund-of-funds activity or limited partner commitments to external venture funds have been disclosed publicly. The office's known activity consists of direct early-stage equity investments, consistent with a single-family office approach that favors concentrated positions over diversified fund portfolio construction.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: